Indictment — USA v. Khaim (Dkt. 1, E.D.N.Y.)

Summary

A grand jury indictment in United States v. Peter Khaim and Arkadiy Khaimov, No. 1:20-cr-00580(AMD)(RML), in the U.S. District Court for the Eastern District of New York, filed December 18, 2020 as Document 1. The caption cites charges under Title 18 including §§ 1349, 1028A(a)(1) and 1956(h). The indictment describes Medicare Part D and Medicaid rules for pharmacies, prior authorization for Targretin Gel 1%, priced above approximately $34,000 for each 60 gram tube, and emergency override codes that COVID-19 declarations made available. It alleges that the defendants owned, controlled and operated thirteen New York pharmacy companies it calls the Scheme Pharmacies, and that proceeds were laundered through pass-through entities controlled by a person it calls Money Launderer 1. It closes with forfeiture allegations and is marked a true bill.

Summary drafted by a model from the text of the original file linked on this page and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used